Boeing vs. Space Exploration Technologies: Which Flight Giant Is a Better Buy in 2026?

Boeing reported FY2025 revenue of nearly $90 billion, up approximately 35% year over year, and returned to roughly $2.2 billion of net income, although free cash flow remained negative $1.9 billion and debt-to-equity was elevated at 10x. The article favors Boeing as a contrarian long-term value play, citing an expected 9% rise in 2026 revenue to $97.7 billion and a record, double-digit increase in backlog, despite projected net income falling to about $85 million. SpaceX delivered roughly $18.7 billion of FY2025 revenue, up 33%, and Starlink reached 10.3 million subscribers, but its nearly $5 billion net loss and negative $14 billion free cash flow underscore the capital intensity behind its premium 68.4x price-to-sales valuation.

Analysis

The key investable issue is not relative revenue growth but conversion of aerospace backlog into cash. BA’s equity remains a levered call on FAA-approved production-rate normalization: incremental deliveries can drive sharp working-capital release, but weak free cash flow means a delivery or rework disruption would disproportionately pressure liquidity, debt costs, and the recovery multiple. The more direct listed beneficiaries of a sustained civil-aerospace supply-chain normalization may be GE (LEAP engine aftermarket), HWM (forgings), and HEI (avionics), which have less certification headline risk than BA.

The SpaceX comparison is not presently actionable without verification. SPCX is not a standard publicly traded SpaceX listing, and the article’s IPO, valuation, and financial figures should not be used for position sizing until independently confirmed through exchange filings and audited disclosures. If a genuine listing occurs, the market is likely to value Starlink on subscriber growth and terminal economics rather than near-term earnings; the critical sensitivity is capex per incremental subscriber, since persistent satellite replenishment spending can turn apparent scale into structurally negative free cash flow.

Consensus may be too focused on BA’s low sales multiple and too dismissive of the duration of its cash-recovery problem. A low P/S is not protective when production quality, customer compensation, and inventory monetization determine free cash flow; conversely, a verified SpaceX listing could command an extreme scarcity premium regardless of losses. Over the next 1-3 months, monitor FAA production decisions, BA delivery cadence, supplier bottlenecks, and defense fixed-price charge trends; over 6-18 months, the decisive variable is whether BA can sustain positive FCF after customer advances unwind.

Key Decisions for Investors

• Do not initiate any SPCX position or use the stated valuation metrics until ticker eligibility, listing status, float, and audited financials are independently verified; treat a confirmed IPO filing as an event-driven research alert rather than a buy signal.
• Maintain BA as a tactical watch rather than a core long. Enter only after two consecutive months of improving commercial deliveries and reaffirmed free-cash-flow guidance; target a 6-12 month rerating on production stability, with thesis invalidated by an FAA production restriction, renewed quality event, or negative FCF guidance revision.
• Prefer a 6-12 month relative-value basket long GE/HWM/HEI versus BA for aerospace recovery exposure. These suppliers retain upside from higher build rates while reducing exposure to BA-specific certification, customer-compensation, and balance-sheet risk.
• For defense exposure, favor LMT or NOC over a speculative SpaceX proxy until verified disclosure permits segment-level underwriting. Reassess if commercial launch pricing compresses materially or U.S. procurement shifts toward lower-cost launch providers.